1x7s Citations

X-ray crystallographic studies of two transthyretin variants: further insights into amyloidogenesis.

Acta Crystallogr D Biol Crystallogr 61 333-9 (2005)
Cited: 8 times
EuropePMC logo PMID: 15735344

Abstract

Transthyretin (TTR) is a homotetrameric plasma protein that, as a result of a set of not yet fully characterized conformational changes, forms fibrillar aggregates that are the major protein component of amyloid deposits. More than 80 mutations associated with TTR amyloid deposition have been described in the literature. X-ray crystallography was used to elucidate the three-dimensional structure of two important TTR variants: TTR Y78F, an amyloidogenic protein, and TTR R104H, which is associated with a protective effect over the amyloidogenic V30M mutation. The structures of those two TTR variants have been determined in space group P2(1)2(1)2 to 1.55 and 1.60 angstroms resolution, respectively, using molecular-replacement techniques. Detailed analysis of the protein model for TTR Y78F indicates a destabilization of the contacts between the alpha-helix and AB loop and the body of the molecule, intimately related to the amyloidogenic nature; contrastingly, in the TTR R104H variant new contacts involving the N-terminal region and His104 are clearly antagonists of amyloid formation.

Reviews citing this publication (1)

  1. Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses. Connelly S, Choi S, Johnson SM, Kelly JW, Wilson IA. Curr Opin Struct Biol 20 54-62 (2010)

Articles citing this publication (7)

  1. Structural insight into pH-induced conformational changes within the native human transthyretin tetramer. Palaninathan SK, Mohamedmohaideen NN, Snee WC, Kelly JW, Sacchettini JC. J Mol Biol 382 1157-1167 (2008)
  2. Amyloidogenic potential of transthyretin variants: insights from structural and computational analyses. Cendron L, Trovato A, Seno F, Folli C, Alfieri B, Zanotti G, Berni R. J Biol Chem 284 25832-25841 (2009)
  3. Enthalpy-Driven Stabilization of Transthyretin by AG10 Mimics a Naturally Occurring Genetic Variant That Protects from Transthyretin Amyloidosis. Miller M, Pal A, Albusairi W, Joo H, Pappas B, Haque Tuhin MT, Liang D, Jampala R, Liu F, Khan J, Faaij M, Park M, Chan W, Graef I, Zamboni R, Kumar N, Fox J, Sinha U, Alhamadsheh M. J Med Chem 61 7862-7876 (2018)
  4. R104H may suppress transthyretin amyloidogenesis by thermodynamic stabilization, but not by the kinetic mechanism characterizing T119 interallelic trans-suppression. Sekijima Y, Dendle MT, Wiseman RL, White JT, D'Haeze W, Kelly JW. Amyloid 13 57-66 (2006)
  5. The putative role of some conserved water molecules in the structure and function of human transthyretin. Banerjee A, Dasgupta S, Mukhopadhyay BP, Sekar K. Acta Crystallogr D Biol Crystallogr 71 2248-2266 (2015)
  6. Thermodynamic Stability and Aggregation Kinetics of EF Helix and EF Loop Variants of Transthyretin. Ferguson JA, Sun X, Dyson HJ, Wright PE. Biochemistry 60 756-764 (2021)
  7. An insight to the conserved water mediated dynamics of catalytic His88 and its recognition to thyroxin and RBP binding residues in human transthyretin. Banerjee A, Mukhopadhyay BP. J Biomol Struct Dyn 33 1973-1988 (2015)